A chemiluminescence analyzer can be defined as a device that detects radiation or light produced in a chemical reaction when a chemical entity returns from an electronic excited state to its stable form.
The higher sensitivity and accuracy of chemiluminescence immunoassay (CLIA) over enzyme-linked immunosorbent assay (ELISA) will drive the growth prospects for the market in the coming years.
Benchtop analyzers are highly adopted in various local research, diagnostic centers, and smaller hospitals. 

The global Chemiluminescence Analyzer (CLA) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Chemiluminescence Analyzer (CLA) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chemiluminescence Analyzer (CLA) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Chemiluminescence Analyzer (CLA) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Chemiluminescence Analyzer (CLA) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abbott Laboratories
Beckman Coulter
bioMérieux SA
F. Hoffmann-La Roche
Siemens Healthineers
Biokit
DiaSorin
Ortho Clinical Diagnostics

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Benchtop
Floor-Standing

Segment by Application
Hospitals and Diagnostic Centers
Research Laboratories
Pharma and Biotech Companies
Academic Research Centers